InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,686.46
(
-0.40%
)
US TECH 100
19,235.20
(
-0.22%
)
Dow Jones
41,928.13
(
-0.64%
)
Brent Oil
77.80
(
4.26%
)
Bitcoin
60,692.75
(
0.11%
)
Post# of 346422
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

aikifredicist

Send PM Follow Ignore
Followers 16
Posts 395
Boards Moderated 0
Alias Born 06/07/2009

aikifredicist

Re: None

Sunday, 12/02/2012 11:41:43 AM

Sunday, December 02, 2012 11:41:43 AM

Post# of 346422
After watching BioCentury This Week broadcast this morning (http://www.biocenturytv.com) on the new FDA breakthrough pathway to drug approval I wonder if a doubling in MOS in the most aggressive cancers would qualify?
Any thoughts...???
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Start posting your company's news
Only $200 per official company press release!